Humanin
A mitochondria-associated peptide frequently discussed in longevity circles for cytoprotective and metabolic-interest pathways.
Also appears in: Metabolic
What has the price actually done?
Daily, exact-comparability offers. Discounts use the terms known on each historical date.
How this history is calculated
Effective price per mg uses an active dated override first, then the row-level historical discount, then the vendor default from the same Git revision. Aggregate chart points include exact-comparability offers only. Missing observations remain gaps; the series does not interpolate across unavailable offers or absent snapshots.
Let the market come to you.
Watch the best market price or one vendor. Get one email when Humanin 10mg crosses your target, drops, or sets a new tracked low—without daily noise.
This name primarily lives in the research market and should not be read like an approved pharmaceutical product.
Primary research area: Longevity. Also surfaces under Metabolic for browsing and discovery.
No major aliases are tracked for this profile yet.
No FDA label signal · 7 trials · 542 PubMed results
Current evidence for Humanin is limited to laboratory or animal studies — there are no name-matched human trials with reported results. Any claims about effects in people are not yet backed by clinical data.
Humanin has 4 name-matched clinical trials (highest phase: no phased trial) and 542 PubMed-indexed publications and is not FDA-approved. Note: 3 retracted publications in the literature.
Re-checked nightly against the registries — tracked since 2026-07-09. No band changes yet.
Grades evidence strength, not efficacy or safety. Research-use context; not medical advice. Graded 2026-09-08 from PubMed, ClinicalTrials.gov, ISRCTN, openFDA, Health Canada, and OpenAlex — computed deterministically and refreshed nightly, with a retraction check. How we grade →
What humanin is
Humanin is a mitochondria-associated peptide that appears in longevity and cell-protection discussions. It is usually framed around stress resistance, metabolic signaling, or age-related research interest.
Why it matters
Humanin helps broaden the anti-aging category beyond generic cosmetic language. It represents the more mechanism-heavy side of the longevity peptide conversation.
Regulatory context
Humanin is not FDA approved in the United States and belongs in the research-market category.
Practical reading note
Longevity peptides often attract high-concept marketing, so it is worth separating interesting biology from any claim of proven clinical anti-aging benefit.